146 related articles for article (PubMed ID: 15906183)
1. American Association for Cancer Research--96th Annual Meeting. Anticancer agents--part II.
Phillips T; Collins T; Davies J
IDrugs; 2005 Jun; 8(6):446-9. PubMed ID: 15906183
[No Abstract] [Full Text] [Related]
2. American Association for Cancer Research--96th Annual Meeting. Targeting the cell cycle and HDAC inhibitors.
Phillips T; Collins T; Davies J
IDrugs; 2005 Jun; 8(6):450-3. PubMed ID: 15906184
[No Abstract] [Full Text] [Related]
3. American Association for Cancer Research--96th Annual Meeting. Anticancer agents-part I.
Phillips T; Collins T; Davies J
IDrugs; 2005 Jun; 8(6):443-5. PubMed ID: 15906182
[No Abstract] [Full Text] [Related]
4. American Association for Cancer Research--100th Annual Meeting. HDAC inhibitors, proteasome inhibitors and vascular disrupting agents. 18-22 April 2009, Denver, CO, USA.
Mitra AP
IDrugs; 2009 Jun; 12(6):339-41. PubMed ID: 19517310
[No Abstract] [Full Text] [Related]
5. American Association of Cancer Research--95th annual meeting. Highlights. 27-31 March, 2004, Orlando, FL, USA.
Kibble A; Davies J
IDrugs; 2004 May; 7(5):416-9. PubMed ID: 15154096
[No Abstract] [Full Text] [Related]
6. American association for cancer research--96th annual meeting. Kinases.
Phillips T; Collins T; Davies J
IDrugs; 2005 Jun; 8(6):458-60. PubMed ID: 15906186
[No Abstract] [Full Text] [Related]
7. American Association for Cancer Research--99th Annual Meeting. Clinical and preclinical data on promising therapeutics.
Karger GA; Lee W
IDrugs; 2008 Jun; 11(6):415-7. PubMed ID: 18509781
[No Abstract] [Full Text] [Related]
8. American Association of Cancer Research--95th annual meeting. Kinases. 27-31 March, 2004, Orlando, FL, USA.
Kibble A; Davies J
IDrugs; 2004 May; 7(5):411-3. PubMed ID: 15154094
[No Abstract] [Full Text] [Related]
9. American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part II.
Filson S
IDrugs; 2007 Jun; 10(6):359-61. PubMed ID: 17641994
[No Abstract] [Full Text] [Related]
10. American Society of Hematology--47th annual meeting and exposition.
Murch L
IDrugs; 2006 Feb; 9(2):84-6. PubMed ID: 16523392
[No Abstract] [Full Text] [Related]
11. American Society of Clinical Oncology-39th Annual Meeting. Investigational Drugs. 31 May-3 June 2003, Chicago, IL, USA.
Erlich R; Durrance A
IDrugs; 2003 Jul; 6(7):628-30. PubMed ID: 12906005
[No Abstract] [Full Text] [Related]
12. American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part I.
Kneller S
IDrugs; 2007 Jun; 10(6):356-8. PubMed ID: 17641993
[No Abstract] [Full Text] [Related]
13. Topoisomerase II inhibitors.
Clapp JM; Hande KR
Cancer Chemother Biol Response Modif; 2002; 20():125-49. PubMed ID: 12703203
[No Abstract] [Full Text] [Related]
14. American Association for Cancer Research--96th Annual Meeting. Growth factor receptors.
Phillips T; Collins T; Davies J
IDrugs; 2005 Jun; 8(6):454-7. PubMed ID: 15906185
[No Abstract] [Full Text] [Related]
15. Advances in cancer drug discovery - a British association for cancer research meeting.
Westwell AD
IDrugs; 2008 Nov; 11(11):783-6. PubMed ID: 18988118
[TBL] [Abstract][Full Text] [Related]
16. [Topotecan: a new discovery and future prospects].
Bianco AR
Tumori; 1999; 85(6 Suppl 1):S1-2. PubMed ID: 10786193
[No Abstract] [Full Text] [Related]
17. Inhibitors of histone-deacetylases.
Pelicci PG
Tumori; 2001; 87(6):S12-4. PubMed ID: 11989609
[No Abstract] [Full Text] [Related]
18. American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part III.
Sovran L
IDrugs; 2007 Jun; 10(6):362-5. PubMed ID: 17641995
[No Abstract] [Full Text] [Related]
19. American Association for Cancer Research--97th Annual Meeting.
Kneller S; Yager N
IDrugs; 2006 May; 9(5):334-7. PubMed ID: 16676267
[No Abstract] [Full Text] [Related]
20. Biological approaches to therapy of pancreatic cancer.
Wong HH; Lemoine NR
Pancreatology; 2008; 8(4-5):431-61. PubMed ID: 18724071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
